Theriva Biologics, Inc. (TOVX)
NYSEAMERICAN: TOVX · Real-Time Price · USD
0.4710
+0.0130 (2.84%)
At close: Jun 5, 2025, 4:00 PM
0.4514
-0.0196 (-4.16%)
After-hours: Jun 5, 2025, 7:07 PM EDT
Theriva Biologics Market Cap
Theriva Biologics has a market cap or net worth of $3.76 million as of June 5, 2025. Its market cap has decreased by -41.28% in one year.
Market Cap
3.76M
Enterprise Value
-3.31M
1-Year Change
-41.28%
Ranking
Category
Stock Price
$0.47
Market Cap Chart
Since April 2, 2007, Theriva Biologics's market cap has decreased from $81.60M to $3.76M, a decrease of -95.39%. That is a compound annual growth rate of -15.57%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 4, 2025 | 3.70M | -24.49% |
| Dec 31, 2024 | 4.90M | -32.88% |
| Dec 29, 2023 | 7.30M | 1.39% |
| Dec 30, 2022 | 7.20M | -79.94% |
| Dec 31, 2021 | 35.90M | 366.23% |
| Dec 31, 2020 | 7.70M | -9.41% |
| Dec 31, 2019 | 8.50M | 11.84% |
| Dec 31, 2018 | 7.60M | -88.36% |
| Dec 29, 2017 | 65.30M | -7.11% |
| Dec 30, 2016 | 70.30M | -66.19% |
| Dec 31, 2015 | 207.90M | 96.32% |
| Dec 31, 2014 | 105.90M | 55.05% |
| Dec 31, 2013 | 68.30M | -11.18% |
| Dec 31, 2012 | 76.90M | 116.62% |
| Dec 30, 2011 | 35.50M | 22.84% |
| Dec 31, 2010 | 28.90M | 140.83% |
| Dec 31, 2009 | 12.00M | 224.32% |
| Dec 31, 2008 | 3.70M | -96.22% |
| Dec 31, 2007 | 97.80M | 19.85% |
View and export this data all the way back to 2007.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 675.45B |
| Johnson & Johnson | 372.15B |
| AbbVie | 330.23B |
| Novo Nordisk | 323.14B |
| UnitedHealth Group | 273.16B |
| Abbott Laboratories | 230.96B |
| Novartis AG | 228.01B |
| AstraZeneca | 222.18B |